LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling.

Saved in:
Bibliographic Details
Title: LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling.
Authors: Ma Y; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.; Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Zhu Y; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA., Shang L; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.; University of Michigan Rogel Cancer Center, Ann Arbor, MI, 48109, USA., Qiu Y; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA., Shen N; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Wang J; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA., Adam T; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA., Wei W; Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, China., Song Q; Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA., Li J; Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA., Wicha MS; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA. mwicha@med.umich.edu.; University of Michigan Rogel Cancer Center, Ann Arbor, MI, 48109, USA. mwicha@med.umich.edu., Luo M; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA. mingluo@med.umich.edu.; University of Michigan Rogel Cancer Center, Ann Arbor, MI, 48109, USA. mingluo@med.umich.edu.; Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, China. mingluo@med.umich.edu.
Source: Oncogene [Oncogene] 2023 May; Vol. 42 (18), pp. 1419-1437. Date of Electronic Publication: 2023 Mar 15.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5594
DOI:10.1038/s41388-023-02652-3